RPCI Cancer Talk

Friday, October 20, 2017 - 10:34am
Cancer Support
There are many advantages to seeking treatment for pancreatic cancer at a National Cancer Institute-designated cancer center, where doctors specialize and are experienced in treating pancreatic cancer. Pancreatic cancer specialists often take a coordinated approach to treatment, providing a team of medical professionals to develop a personalized care plan for each patient.
Friday, October 6, 2017 - 3:34pm
Patient Stories

Four weeks after her 33rd birthday, Crystal found a lump in her breast. When she told a good friend and co-worker — whose mother happened to be in treatment for metastatic breast cancer — the friend told her, “Don’t mess around.”

Friday, October 6, 2017 - 11:26am
Life & Wellness
Borderline ovarian tumors represent a small subset of epithelial ovarian tumors. Because it’s an uncommon and unfamiliar diagnosis, it’s often misunderstood.
Monday, October 2, 2017 - 4:18pm
Patient Stories

I was told the tumor was inoperable and I had two years to live if I received chemotherapy and radiation. Just two years.

Saturday, September 30, 2017 - 9:00am
Cancer Research & News

We have heard lots of information lately about talcum powder use and the risk of ovarian cancer.

Friday, September 29, 2017 - 5:05pm
Cancer Support

Hormone therapy causes side effects that can have a serious impact on the patient's quality of life, but men are often reluctant to talk about them or ask for help. A new education group aims to get the word out: "There is hope."

Thursday, September 28, 2017 - 2:57pm
Cancer Research & News

“Initially, ovarian cancer, melanoma, and some sarcomas are the three main targets,” says Dr. Koya, “but the clinical trial is open for patients with other cancers who meet the eligibility requirements."

Tuesday, September 26, 2017 - 3:21pm
Patient Stories

My son, David, was 13 years old when he was diagnosed with acute lymphoblastic leukemia (ALL). My husband and I are both medical professionals, and cancer never entered our minds when David exhibited signs of fatigue, sore throat and listlessness. 

Monday, September 25, 2017 - 10:26am
Cancer Research & News

Collected last week from a patient with late-stage ovarian cancer, these are not ordinary T cells; they have been altered and multiplied in the hope that when they are given back to her, they will launch a devastating attack on her cancer cells.